Big Pharma CEOs Must "Earn Trust" For Industry, Schering-Plough's Hassan Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Drug industry "needs to respond more effectively" to clash between belief in free market incentives and demands of society for access to medicine, Hassan says. For Schering, earning trust begins with renewed commitment to business integrity.
You may also be interested in...
Schering Names Project Management, Pharmaceutical Science Execs
Johnson & Johnson exec Susan Welsh joins Schering-Plough Research Institute as group VP-global project management where she will oversee R&D licensing. Rene Imwinkelried comes from Lonza Group to become VP-chemical development.
Schering Names Project Management, Pharmaceutical Science Execs
Johnson & Johnson exec Susan Welsh joins Schering-Plough Research Institute as group VP-global project management where she will oversee R&D licensing. Rene Imwinkelried comes from Lonza Group to become VP-chemical development.
PhRMA “FastAccess” Doubles Monthly Visits To Patient Assistance Website
Approximately 100,000 visitors per month have logged onto PhRMA’s HelpingPatients.org since the “Fast Access” online patient enrollment system launch April 1. The site previously had about 50,000 visitors per month.